Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Dow
Medtronic
Boehringer Ingelheim
Moodys

Last Updated: June 26, 2022

CLINICAL TRIALS PROFILE FOR ADEMETIONINE


✉ Email this page to a colleague

« Back to Dashboard

Clinical Trials for Ademetionine

Trial ID Title Status Sponsor Phase Summary
NCT01998620 ↗ Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis Unknown status Zhejiang Hisun Pharmaceutical Co. Ltd. Phase 4 This is an evaluation of adenosine methionine for treatment of chronic hepatitis b patients with cholestasis efficacy and safety of multicenter, randomized, open label clinical trial.
NCT02200029 ↗ Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption Completed Ascent Phase 3 A research study of an approved drug called Heptral®, ademetionine, to treat adults with intrahepatic cholestasis (a condition where bile cannot flow from the liver to the duodenum) in pre-cirrhotic and cirrhotic states. Experience from clinical studies in subjects with liver disease has shown that ademetionine is effective.
NCT02200029 ↗ Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption Completed Catalent Phase 3 A research study of an approved drug called Heptral®, ademetionine, to treat adults with intrahepatic cholestasis (a condition where bile cannot flow from the liver to the duodenum) in pre-cirrhotic and cirrhotic states. Experience from clinical studies in subjects with liver disease has shown that ademetionine is effective.
NCT02200029 ↗ Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption Completed ClinIntel Phase 3 A research study of an approved drug called Heptral®, ademetionine, to treat adults with intrahepatic cholestasis (a condition where bile cannot flow from the liver to the duodenum) in pre-cirrhotic and cirrhotic states. Experience from clinical studies in subjects with liver disease has shown that ademetionine is effective.
NCT02200029 ↗ Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption Completed Datamap Phase 3 A research study of an approved drug called Heptral®, ademetionine, to treat adults with intrahepatic cholestasis (a condition where bile cannot flow from the liver to the duodenum) in pre-cirrhotic and cirrhotic states. Experience from clinical studies in subjects with liver disease has shown that ademetionine is effective.
NCT02200029 ↗ Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption Completed Abbott Phase 3 A research study of an approved drug called Heptral®, ademetionine, to treat adults with intrahepatic cholestasis (a condition where bile cannot flow from the liver to the duodenum) in pre-cirrhotic and cirrhotic states. Experience from clinical studies in subjects with liver disease has shown that ademetionine is effective.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for Ademetionine

Condition Name

Condition Name for
Intervention Trials
Drug-induced Liver Injury,Chronic 2
Hepatitis B 2
Intrahepatic Cholestasis Associated With Alcoholic Liver Disease 1
Liver Failure 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for
Intervention Trials
Chemical and Drug Induced Liver Injury 3
Liver Diseases 2
Drug-Induced Liver Injury 2
Cholestasis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Ademetionine

Trials by Country

Trials by Country for
Location Trials
China 5
Russian Federation 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Ademetionine

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase Trials
Phase 4 3
Phase 3 1
Phase 1/Phase 2 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase Trials
Completed 3
Unknown status 2
Active, not recruiting 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Ademetionine

Sponsor Name

Sponsor Name for
Sponsor Trials
Beijing 302 Hospital 3
Zhejiang Hisun Pharmaceutical Co. Ltd. 1
Ascent 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for
Sponsor Trials
Industry 7
Other 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
McKinsey
Boehringer Ingelheim
Colorcon
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.